FDA Inspection 1248187 — Shady Grove Fertility Reproductive Science Center
The FDA completed an inspection of Shady Grove Fertility Reproductive Science Center on Aug 15, 2024 in Washington, DC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 15, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Washington, DC (United States)